Viral Hepatitis / Projects

3rd Health Programme (2014-2020)
AIDS Action Europe - Continuity and Innovation 2017 [AAE]
Under its leading motto for the Framework Partnership Agreement, continuity and innovation, AIDS Action Europe (AAE) will maintain to work in 2017. As a comprehensive NGO network in the field of HIV/A...
Under its leading motto for the Framework Partnership Agreement, continuity and innovation, AIDS Action Europe (AAE) will maintain to work in 2017. As a comprehensive NGO network in the field of HIV/AIDS with over 400 network members and partners AAE is a unique player with substantial added value for European policy making and programme implementation. Based on the problem analysis and the activities implemented in 2015 and 2016, AAE will focus on tackling following core problem areas in 2017:
Advocacy for a new policy framework
Advocacy for European issues at the international level
Upscaling access to prevention for gay men and other MSM
Improved access to HIV services for all those whose access is limited due to their residency status
Affordability of medicines and access to treatment
Community based voluntary counselling and testing (CBVCT) outside medical settings
and tackling stigma and discrimination
Within Objective I, AAE will ensure that Civil Society’s voices are being heard and key populations’ needs are addressed by organising the EU HIV/AIDS CSF, contributing to the Think Tank, contributing to key European events and participating in the UNAIDS PCB. Furthermore AAE will continue its activities regarding undocumented migrants, affordability of medicines, promoting CBVCT and upscaling access to prevention for gay men and other MSM. Tackling stigma and discrimination is a core task for AAE and is reflected as a cross sectional theme in all our activities. AAE will advocate for the rights of key populations and contribute to fairer, inequality reducing societies. Under Objective II communication and collaboration, facilitate linking and learning between members and partners are at focus with a recently re-launched and re-designed AAE Clearinghouse and website as well as through our social media presence. Objective III will ensure overall governance, the functioning of the network and the implementation of the annual work programme.

Start date: 01/01/2017 - End date: 31/12/2017

Call: Financial contribution to the functioning of non-governmental bodies (Operating grants)
Topic: Viral Hepatitis
3rd Health Programme (2014-2020)
Joint Action on integrating prevention, testing and linkage to care strategies acros HIV, viral hepatitis, TB and STIs in Europe (INTEGRATE) [INTEGRATE]
The “Joint Action on integrating prevention, testing and link to care strategies across HIV, Viral Hepatitis, TB & STIs in Europe” (INTEGRATE) has the overall objective to increase Integrated earl...
The “Joint Action on integrating prevention, testing and link to care strategies across HIV, Viral Hepatitis, TB & STIs in Europe” (INTEGRATE) has the overall objective to increase Integrated early diagnosis and linkage to prevention and care of HIV, viral hepatitis, TB and STIs in EU Member States by 2020.
A number of tools have been developed to reduce transmission, optimize early diagnosis and linkage to care for one or more of these four diseases. INTEGRATE will map relevant existing tools for cross-linking. A peer-review process will identify which of these tools are complimentary or redundant for other disease(s), and which could be adapted or require further innovation.
HIV, viral hepatitis, TB and STIs are cross-borders public health threats of concern to Europe that affect vulnerable populations disproportionately and require personalised interventions. As multiple dimensional approaches are required to reduce the public health burden, the most optimal profile of approaches that provide additive effects (and that are reasonably cost-effective) should be identified and implemented broadly.
INTEGRATE provides a platform to disseminate and exchange best practice among Member States and facilitate discussions on innovations and emerging issues within the four diseases. In this respect, INTEGRATE is a shared European effort that extends beyond the partners and can create important synergies across European stakeholders, projects and initiatives.
INTEGRATE supports the implementation of the Commission Communication on ‘Combating HIV/AIDS in the European Union and neighboring countries’ and the ‘Action Plan on HIV/AIDS in the EU and neighboring countries’ by ensuring better preparedness across the EU and by identifying innovative evidence-based testing and prevention tools to reduce new cases of HIV, viral hepatitis, TB and STIs in priority groups.
Start date: 01/09/2017 - End date: 28/02/2021

Call: Joint Actions 2016
Topic: Viral Hepatitis